Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group

Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer?

(2010) A.G. Pallis et al.   CANCER TREATMENT REVIEWS

Questionnaires and instruments for a multidimensional assessment of the older cancer patient: What clinicians need to know?

(2010) A.G. Pallis et al.   EUROPEAN JOURNAL OF CANCER

EORTC elderly task force position paper: Approach to the older cancer patient

(2010) A.G. Pallis et al.   EUROPEAN JOURNAL OF CANCER

EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population

(2009) A. G. Pallis et al.   ANNALS OF ONCOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Management of unfit older patients with advanced NSCLC

(2009) Cesare Gridelli et al.   CANCER TREATMENT REVIEWS

Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

(2008) Paul Wheatley-Price et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy in Elderly Patients with Colorectal Cancer

(2008) C.-H. Kohne et al.   ONCOLOGIST

Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599

(2007) Suresh S. Ramalingam et al.   JOURNAL OF CLINICAL ONCOLOGY

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial

(2007) Vassilis Georgoulias et al.   LUNG CANCER